ARCHIVES

BMS Demands Resignation Of Two ImClone Executives

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Proposes Consolidation of Nine Cooperative Groups to Four

December 17, 2010

FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA

July 3, 1981

Centers’ Problems Get Increasing Attention From Staff, Advisors

August 20, 1976

Act To Get Only One-Year Extension Now NCAB; ACCC, ACI Adopt Recommendations For changes

February 4, 1977

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

April 29, 1988

NCCS Networker Volume 10 Issue 1, Spring 1996

April 13, 1996